Skip to main content
Erschienen in: Child's Nervous System 9/2015

01.09.2015 | Original Paper

Low-grade gliomas in children: single institutional experience in 198 cases

verfasst von: Magda Garzón, Gemma García-Fructuoso, Mariona Suñol, Jaume Mora, Ofelia Cruz

Erschienen in: Child's Nervous System | Ausgabe 9/2015

Einloggen, um Zugang zu erhalten

Abstract

Introduction

In pediatric population (0–18 years), low-grade gliomas (PLGG) are the most frequent brain tumors and majority are amenable for surgical removal.

Patients and methods

A retrospective review of 198 children diagnosed with PLGG between 1980 and 2010 at HSJD was carried out. Several variables were studied to find prognostic factors related to the outcomes (progression-free survival (PFS) and overall survival (OS)).

Results

Median age at onset was 88.8 months (3.1 to 214.5 months, SD 53). Surgery was performed in 175 patients (88.4 %), achieving gross total resection (GTR) in 77 (44 %), subtotal resection (STR) in 87 (49.7 %), and 11 (6.3 %) biopsies. Pathological review classified 84 tumors as WHO grade I (48 %) and 89 as grade II (50.8 %). Adjuvant therapy (AT) was given to 75 patients (37.9 %), radiotherapy in 24 (12.1 %), chemotherapy in 33 (16.7 %), and combined in 18 (9.1 %). Sixteen patients (8.1 %) died, 89 (43.4 %) are alive with no evidence of disease, and 93 (47 %) alive with disease, median follow-up 65.2 months. Outcome is significantly correlated with age (p = 0001, worse OS for patients younger than 12 months) and extent of tumor resection (p < 0001). OS for GTR/STR/biopsy was >200, 154.3, and 101.9 months, respectively. Patients treated with AT presented worse OS/PFS (p < 0.001) than those not treated. Histology was non significantly related to outcomes.

Conclusion

In our series of PLGG, the best prognostic markers are tumor location (cerebellar) and the extent of tumor resection (GTR). Infants and patients who require adjuvant therapy because of tumor progression or recurrence have worse outcome.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Ater J, Holmes E, Zhou T, et al (2012) Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children. J Clin Oncol 30(21):2641–2647PubMedCentralCrossRefPubMed Ater J, Holmes E, Zhou T, et al (2012) Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children. J Clin Oncol 30(21):2641–2647PubMedCentralCrossRefPubMed
2.
Zurück zum Zitat Bandopadhayay P, Bergthold G, London WB, Goumnerova LC, Morales La Madrid A, Markus K, et al (2014) Long-term outcome of 4040 children diagnosed with pediatric low-grade gliomas: an analysis of the Surveillance Epidemiology and End Results (SEER) database. Pediatr Blood Cancer 61(7):1173–1179CrossRefPubMed Bandopadhayay P, Bergthold G, London WB, Goumnerova LC, Morales La Madrid A, Markus K, et al (2014) Long-term outcome of 4040 children diagnosed with pediatric low-grade gliomas: an analysis of the Surveillance Epidemiology and End Results (SEER) database. Pediatr Blood Cancer 61(7):1173–1179CrossRefPubMed
3.
Zurück zum Zitat Beebe DW, Ris MD, Armostrong FD, Fontanesi J, Mulhern R, Holmes E, Wisoff JH (2005) Cognitive and adaptative outcome in low grade pediatric cerebellar astrocytomas: evidence of diminished cognitive and adaptative functioning in national collaborative research studies (CCG 9891/POG 9130). J Clin Oncol 23:5198–5204CrossRefPubMed Beebe DW, Ris MD, Armostrong FD, Fontanesi J, Mulhern R, Holmes E, Wisoff JH (2005) Cognitive and adaptative outcome in low grade pediatric cerebellar astrocytomas: evidence of diminished cognitive and adaptative functioning in national collaborative research studies (CCG 9891/POG 9130). J Clin Oncol 23:5198–5204CrossRefPubMed
4.
Zurück zum Zitat Bristol RE (2009) Low-grade glial tumors: are they all the same? Semin Pediatr Neurol 16(1):23–26CrossRefPubMed Bristol RE (2009) Low-grade glial tumors: are they all the same? Semin Pediatr Neurol 16(1):23–26CrossRefPubMed
5.
Zurück zum Zitat CBTRUS. Statistical Report (2005) Primary brain tumors in the United States, 1998–2002. Central Brain Tumor Registry of the United States, Hinsdale CBTRUS. Statistical Report (2005) Primary brain tumors in the United States, 1998–2002. Central Brain Tumor Registry of the United States, Hinsdale
6.
Zurück zum Zitat Choi KC, Kwak SE, Kim JE, Sheen SH, Kang TC (2009) Enhanced glial fibrillary acidic protein-delta expression in human astrocytic tumors. Neurosci Lett 463(3):182–187CrossRefPubMed Choi KC, Kwak SE, Kim JE, Sheen SH, Kang TC (2009) Enhanced glial fibrillary acidic protein-delta expression in human astrocytic tumors. Neurosci Lett 463(3):182–187CrossRefPubMed
7.
Zurück zum Zitat Colin C, Padovani L, Chappe C, Merciurio S, Scavarda D, Loundou A, et al (2013) Outcome analysis of childhood pilocytic astrocytomas: a retrospective study of 148 cases at a single institution. Neuropathol Appl Neurobiol 39(6):693–705CrossRefPubMed Colin C, Padovani L, Chappe C, Merciurio S, Scavarda D, Loundou A, et al (2013) Outcome analysis of childhood pilocytic astrocytomas: a retrospective study of 148 cases at a single institution. Neuropathol Appl Neurobiol 39(6):693–705CrossRefPubMed
8.
Zurück zum Zitat Daumas-Duport C, Scheithauer BW, Chodkiewicz JP, et al (1988) Dysembryoplastic neuroepithelial tumor: a surgically curable tumor of young patients with intractable partial seizures. Report of thirty-nine cases. Neurosurgery 23:545–556CrossRefPubMed Daumas-Duport C, Scheithauer BW, Chodkiewicz JP, et al (1988) Dysembryoplastic neuroepithelial tumor: a surgically curable tumor of young patients with intractable partial seizures. Report of thirty-nine cases. Neurosurgery 23:545–556CrossRefPubMed
9.
Zurück zum Zitat De Carli E, Kalifa CM, Raquin J, Lemerle J, Habrand J, Couanet D, et al (2010) Premature deaths and severe morbidity in 192 long-term survivors of pediatric pathway tumors (OPT): a 50-year study. J Clin Oncol 28:15s(suppl; abstr 9555) De Carli E, Kalifa CM, Raquin J, Lemerle J, Habrand J, Couanet D, et al (2010) Premature deaths and severe morbidity in 192 long-term survivors of pediatric pathway tumors (OPT): a 50-year study. J Clin Oncol 28:15s(suppl; abstr 9555)
10.
Zurück zum Zitat Drake J, Singhal A, Kulkarni A, De Veber G, Cochrane D, Canadian Pediatric Neurosurgery Study Group (2012) Consensus definitions of complications for accurate recording and comparisons of surgical outcomes in pediatric neurosurgery. J Neurosurg Pediatr 10(2):89–95CrossRefPubMed Drake J, Singhal A, Kulkarni A, De Veber G, Cochrane D, Canadian Pediatric Neurosurgery Study Group (2012) Consensus definitions of complications for accurate recording and comparisons of surgical outcomes in pediatric neurosurgery. J Neurosurg Pediatr 10(2):89–95CrossRefPubMed
11.
Zurück zum Zitat Due-Tonnessen B, Lundar T, Egge A, Scheie D (2013) Neurosurgical treatment of low-grade cerebellar atrocytoma in children and adolescents: a single consecutive institutional series of 100 patients. J Neurosurg Pediatr 11(3):245–249CrossRefPubMed Due-Tonnessen B, Lundar T, Egge A, Scheie D (2013) Neurosurgical treatment of low-grade cerebellar atrocytoma in children and adolescents: a single consecutive institutional series of 100 patients. J Neurosurg Pediatr 11(3):245–249CrossRefPubMed
12.
Zurück zum Zitat Fakhreddine M, Mahajan A, Penas-Prado M, Weinberg J, et al (2013) Treatment, prognosis factors and outcomes in spinal cord astrocytomas. Neuro-Oncology 15(4):406–412PubMedCentralCrossRefPubMed Fakhreddine M, Mahajan A, Penas-Prado M, Weinberg J, et al (2013) Treatment, prognosis factors and outcomes in spinal cord astrocytomas. Neuro-Oncology 15(4):406–412PubMedCentralCrossRefPubMed
13.
Zurück zum Zitat Fernandez C, Figarella-Branger D, Girard N, et al (2003) Pilocytic astrocytomas in children: prognostic factors—a retrospective study of 80 cases. Neurosurgery 53:544–555CrossRefPubMed Fernandez C, Figarella-Branger D, Girard N, et al (2003) Pilocytic astrocytomas in children: prognostic factors—a retrospective study of 80 cases. Neurosurgery 53:544–555CrossRefPubMed
14.
Zurück zum Zitat Fisher PG, Tihan T, Goldthwaite PT, et al (2008) Outcome analysis of childhood low-grade astrocytomas. Pediatr Blood Cancer 51:245–250CrossRefPubMed Fisher PG, Tihan T, Goldthwaite PT, et al (2008) Outcome analysis of childhood low-grade astrocytomas. Pediatr Blood Cancer 51:245–250CrossRefPubMed
15.
Zurück zum Zitat Fouladi M, Wallace D, Langston JW, et al (2003) Survival and functional outcome of children with hypothalamic/chiasmatic tumors. Cancer 97:1084–1092CrossRefPubMed Fouladi M, Wallace D, Langston JW, et al (2003) Survival and functional outcome of children with hypothalamic/chiasmatic tumors. Cancer 97:1084–1092CrossRefPubMed
16.
Zurück zum Zitat Fouladi M, Jenkins J, Burger P, et al (2001) Pleomorphic xanthoastrocytoma: favorable outcome after complete surgical resection. Neuro-Oncology 3:184–192PubMedCentralPubMed Fouladi M, Jenkins J, Burger P, et al (2001) Pleomorphic xanthoastrocytoma: favorable outcome after complete surgical resection. Neuro-Oncology 3:184–192PubMedCentralPubMed
17.
Zurück zum Zitat Gaiser T, Becker MR, Meyer J, Habel A, Siegelin MD (2009) P53-mediated inhibition of angiogenesis in diffuse low-grade astrocytomas. Neurochem Int 54(7):458–463CrossRefPubMed Gaiser T, Becker MR, Meyer J, Habel A, Siegelin MD (2009) P53-mediated inhibition of angiogenesis in diffuse low-grade astrocytomas. Neurochem Int 54(7):458–463CrossRefPubMed
18.
Zurück zum Zitat Gajjar A, Bhargava R, Jenkins JJ, Heideman R, Sanford RA, Langston JW, et al (1995) Low-grade astrocytoma with neuraxis dissemination at diagnosis. J Neurosurg 83:67–71CrossRefPubMed Gajjar A, Bhargava R, Jenkins JJ, Heideman R, Sanford RA, Langston JW, et al (1995) Low-grade astrocytoma with neuraxis dissemination at diagnosis. J Neurosurg 83:67–71CrossRefPubMed
19.
Zurück zum Zitat Gajjar A, Sanford RA, Heideman R, et al (1997) Low-grade astrocytoma: a decade of experience at St Jude Children’s Research Hospital. J Clin Oncol 15:2792–2799PubMed Gajjar A, Sanford RA, Heideman R, et al (1997) Low-grade astrocytoma: a decade of experience at St Jude Children’s Research Hospital. J Clin Oncol 15:2792–2799PubMed
20.
Zurück zum Zitat Garzon M, Garcia G, Guillen A, Sunol M, Mora M, Cruz O (2013) Brain stem tumors in children and adolescents: single institutional experience. Childs Nerv Syst 29(8):1321–1331 Garzon M, Garcia G, Guillen A, Sunol M, Mora M, Cruz O (2013) Brain stem tumors in children and adolescents: single institutional experience. Childs Nerv Syst 29(8):1321–1331
21.
Zurück zum Zitat Gelpi E et al (2005) Pleomorphic xanthoastrocytoma with anaplastic features presenting without GFAP immunoreactivity: implications for differential diagnosis. Neuropathology 25(3):241–246CrossRefPubMed Gelpi E et al (2005) Pleomorphic xanthoastrocytoma with anaplastic features presenting without GFAP immunoreactivity: implications for differential diagnosis. Neuropathology 25(3):241–246CrossRefPubMed
22.
Zurück zum Zitat Gnekow AK, Falkenstein F, Von Homstein S, Zwiener I, Berkefeld S, Bison B, et al (2012) Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade gliomas in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology. Neuro-Oncology 14(10):1265–1284PubMedCentralCrossRefPubMed Gnekow AK, Falkenstein F, Von Homstein S, Zwiener I, Berkefeld S, Bison B, et al (2012) Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade gliomas in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology. Neuro-Oncology 14(10):1265–1284PubMedCentralCrossRefPubMed
23.
Zurück zum Zitat Gnekow A, Kandels D, Walker D, Perilongo G, et al (2014) Abstracts from the sixteenth international symposium on pediatric neuro-oncology: a randomized trial of intensification of induction-chemotherapy within an 18 months treatment-strategy on tumor-response at 24 weeks and progression-free-survival in pediatric low grade glioma (LGG). Preliminary results of the SIOP-LGG-2004-Working Group. Neuro-Oncology 16:i60–i70. doi:10.1093/neuonc/nou073 CrossRef Gnekow A, Kandels D, Walker D, Perilongo G, et al (2014) Abstracts from the sixteenth international symposium on pediatric neuro-oncology: a randomized trial of intensification of induction-chemotherapy within an 18 months treatment-strategy on tumor-response at 24 weeks and progression-free-survival in pediatric low grade glioma (LGG). Preliminary results of the SIOP-LGG-2004-Working Group. Neuro-Oncology 16:i60–i70. doi:10.​1093/​neuonc/​nou073 CrossRef
24.
Zurück zum Zitat Goodden J, Pizer B, Pettorini B, Williams D, Blair J, Didi M, et al (2014) The role of surgery in optic pathway/hypothalamic gliomas in children. J Neurosur Pediatr 13(1):1–12CrossRef Goodden J, Pizer B, Pettorini B, Williams D, Blair J, Didi M, et al (2014) The role of surgery in optic pathway/hypothalamic gliomas in children. J Neurosur Pediatr 13(1):1–12CrossRef
25.
Zurück zum Zitat Haapasalo J, Mennander A, Helen P, Haapasalo H, Isola J (2005) Ultrarapid Ki-67 immunostaining in frozen section interpretation of gliomas. J Clin Pathol 58:263–268PubMedCentralCrossRefPubMed Haapasalo J, Mennander A, Helen P, Haapasalo H, Isola J (2005) Ultrarapid Ki-67 immunostaining in frozen section interpretation of gliomas. J Clin Pathol 58:263–268PubMedCentralCrossRefPubMed
26.
Zurück zum Zitat Hashiba T, Izumoto S, Kagawa N, Suzuki T, Hashimoto N, Maruno M, Yoshimine T (2007) Expression of WT1 protein and correlation with cellular proliferation in glial tumors. Neurol Med Chir (Tokyo) 47(4):165–170CrossRef Hashiba T, Izumoto S, Kagawa N, Suzuki T, Hashimoto N, Maruno M, Yoshimine T (2007) Expression of WT1 protein and correlation with cellular proliferation in glial tumors. Neurol Med Chir (Tokyo) 47(4):165–170CrossRef
27.
Zurück zum Zitat Hernaiz-Driever P, Von Hornstein S, Pietsch T, Kortmann R, Warmuth-Metz M, Emser A, Gnekow AK (2010) Natural history and management of low-grade glioma in NF1 children. J Neuro-Oncol 100(2):199–207CrossRef Hernaiz-Driever P, Von Hornstein S, Pietsch T, Kortmann R, Warmuth-Metz M, Emser A, Gnekow AK (2010) Natural history and management of low-grade glioma in NF1 children. J Neuro-Oncol 100(2):199–207CrossRef
28.
Zurück zum Zitat Listernick R, Ferner RE, Liu GT, Gutmann DH (2007) Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Ann Neurol 61:189–198CrossRefPubMed Listernick R, Ferner RE, Liu GT, Gutmann DH (2007) Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Ann Neurol 61:189–198CrossRefPubMed
29.
Zurück zum Zitat Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (2007) WHO classification of tumours of the central nervous system, 4th edn. IARC, Lyon, p. 309 Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (2007) WHO classification of tumours of the central nervous system, 4th edn. IARC, Lyon, p. 309
30.
Zurück zum Zitat Marcus KJ, Goumnerova L, Billett AL, et al (2005) Stereotactic radiotherapy for localized low-grade gliomas in children: final results of a prospective trial. Int J Radiat Oncol Biol Phys 61:374–379CrossRefPubMed Marcus KJ, Goumnerova L, Billett AL, et al (2005) Stereotactic radiotherapy for localized low-grade gliomas in children: final results of a prospective trial. Int J Radiat Oncol Biol Phys 61:374–379CrossRefPubMed
31.
Zurück zum Zitat Margraf LR, Gargan L, Butt Y, Raghunathan N, Bowers DC (2011) Proliferative and metabolic markers in incompletely excised pediatric pilocytic astrocytomas—an assessment of 3 new variables in predicting clinical outcome. Neuro-Oncology 13:767–774PubMedCentralCrossRefPubMed Margraf LR, Gargan L, Butt Y, Raghunathan N, Bowers DC (2011) Proliferative and metabolic markers in incompletely excised pediatric pilocytic astrocytomas—an assessment of 3 new variables in predicting clinical outcome. Neuro-Oncology 13:767–774PubMedCentralCrossRefPubMed
32.
Zurück zum Zitat Maurizi P, Ruggiero A, Attinà G, Cefalo MG, Arlotta A, Riccardi R (2008) The prognostic role of Ki-67 in childhood low-grade glioma. Pediatr Med Chir 30(2):73–78PubMed Maurizi P, Ruggiero A, Attinà G, Cefalo MG, Arlotta A, Riccardi R (2008) The prognostic role of Ki-67 in childhood low-grade glioma. Pediatr Med Chir 30(2):73–78PubMed
33.
Zurück zum Zitat Merchant TE, Conklin HM, Wu S, et al (2009) Late effects of conformal radiation therapy for pediatric patients with low-grade glioma: prospective evaluation of cognitive, endocrine, and hearing deficits. J Clin Oncol 27(22):3691–3697PubMedCentralCrossRefPubMed Merchant TE, Conklin HM, Wu S, et al (2009) Late effects of conformal radiation therapy for pediatric patients with low-grade glioma: prospective evaluation of cognitive, endocrine, and hearing deficits. J Clin Oncol 27(22):3691–3697PubMedCentralCrossRefPubMed
34.
Zurück zum Zitat Monje M, Graham Fisher P (2011) Neurosurgical complications following treatment of children with brain tumors. J Pediatr Rehabil Med 4(1):31–36PubMedCentralPubMed Monje M, Graham Fisher P (2011) Neurosurgical complications following treatment of children with brain tumors. J Pediatr Rehabil Med 4(1):31–36PubMedCentralPubMed
35.
Zurück zum Zitat Mora J, Cruz O, Gala S, Navarro R (2007) Successful treatment of childhood intramedullary spinal cord astrocytomas with irinotecan and cisplatin. Neuro-Oncology 9:39–46PubMedCentralCrossRefPubMed Mora J, Cruz O, Gala S, Navarro R (2007) Successful treatment of childhood intramedullary spinal cord astrocytomas with irinotecan and cisplatin. Neuro-Oncology 9:39–46PubMedCentralCrossRefPubMed
36.
Zurück zum Zitat Neervoort FW, Van Ouwerkerk W, Folkersma H, Kaspers G, Vandertop W (2010) Surgical morbidity of pediatric brain tumors: a single center audit. Childs Nerv Syst 26(11):1583–1592PubMedCentralCrossRefPubMed Neervoort FW, Van Ouwerkerk W, Folkersma H, Kaspers G, Vandertop W (2010) Surgical morbidity of pediatric brain tumors: a single center audit. Childs Nerv Syst 26(11):1583–1592PubMedCentralCrossRefPubMed
37.
Zurück zum Zitat Ohgaki H, Kleihues P (2005) Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 64(6):479–489PubMed Ohgaki H, Kleihues P (2005) Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 64(6):479–489PubMed
38.
Zurück zum Zitat Packer RJ, Ater J, Allen J, et al (1997) Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J Neurosurg 86:747–754CrossRefPubMed Packer RJ, Ater J, Allen J, et al (1997) Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J Neurosurg 86:747–754CrossRefPubMed
39.
Zurück zum Zitat Palma L, Celli P, Mariottini A (2004) Long-term follow-up of childhood cerebellar astrocytomas after incomplete resection with particular reference to arrested growth or spontaneous tumor regression. Acta Neurochir 146:581–588CrossRefPubMed Palma L, Celli P, Mariottini A (2004) Long-term follow-up of childhood cerebellar astrocytomas after incomplete resection with particular reference to arrested growth or spontaneous tumor regression. Acta Neurochir 146:581–588CrossRefPubMed
40.
Zurück zum Zitat Pollack F et al (2002) Expression of p53 and prognosis in children with malignant gliomas. N Engl J Med 346(6):420–427CrossRefPubMed Pollack F et al (2002) Expression of p53 and prognosis in children with malignant gliomas. N Engl J Med 346(6):420–427CrossRefPubMed
41.
Zurück zum Zitat Qaddoumi I, Sultan I, Gajjar A (2009) Outcome and prognostic features in pediatric gliomas: a review of 6212 cases from the surveillance, epidemiology, and end results database. Cancer 115:5761–5770PubMedCentralCrossRefPubMed Qaddoumi I, Sultan I, Gajjar A (2009) Outcome and prognostic features in pediatric gliomas: a review of 6212 cases from the surveillance, epidemiology, and end results database. Cancer 115:5761–5770PubMedCentralCrossRefPubMed
42.
Zurück zum Zitat Qaddoumi I, Sultan Y, Broniscer A (2009) Pediatric low-grade gliomas and the need for new options for therapy: why and how? Cancer Biol Ther 8:4–10PubMedCentralCrossRefPubMed Qaddoumi I, Sultan Y, Broniscer A (2009) Pediatric low-grade gliomas and the need for new options for therapy: why and how? Cancer Biol Ther 8:4–10PubMedCentralCrossRefPubMed
44.
46.
Zurück zum Zitat Stokland T, Liu JF, Ironside JW, Ellison DW, Taylor R, Robinson KJ, Picton SV, Walker DA (2010) A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702). Neuro-Oncology 12:1257–1268PubMedCentralPubMed Stokland T, Liu JF, Ironside JW, Ellison DW, Taylor R, Robinson KJ, Picton SV, Walker DA (2010) A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702). Neuro-Oncology 12:1257–1268PubMedCentralPubMed
47.
Zurück zum Zitat Terashima K, Chow K, Jones J, Ahern C, Jo E, Ellezam B, Paulino A, et al (2013) Long-term outcome of centrally located low-grade glioma in children. Cancer 119(14):2630–2638CrossRefPubMed Terashima K, Chow K, Jones J, Ahern C, Jo E, Ellezam B, Paulino A, et al (2013) Long-term outcome of centrally located low-grade glioma in children. Cancer 119(14):2630–2638CrossRefPubMed
48.
Zurück zum Zitat Wisoff JH et al (2011) Primary neurosurgery for pediatric low-grade gliomas: a prospective multi-institutional study from the Children’s Oncology Group. Neurosurgery 68(6):1548–1554 discussion 1554–5CrossRefPubMed Wisoff JH et al (2011) Primary neurosurgery for pediatric low-grade gliomas: a prospective multi-institutional study from the Children’s Oncology Group. Neurosurgery 68(6):1548–1554 discussion 1554–5CrossRefPubMed
Metadaten
Titel
Low-grade gliomas in children: single institutional experience in 198 cases
verfasst von
Magda Garzón
Gemma García-Fructuoso
Mariona Suñol
Jaume Mora
Ofelia Cruz
Publikationsdatum
01.09.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Child's Nervous System / Ausgabe 9/2015
Print ISSN: 0256-7040
Elektronische ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-015-2800-9

Weitere Artikel der Ausgabe 9/2015

Child's Nervous System 9/2015 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.